PRESERVE-MITRAL Post-Market Registry

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

April 10, 2017

Primary Completion Date

February 10, 2021

Study Completion Date

February 10, 2021

Conditions
Mitral Valve Disease
Interventions
DEVICE

Profile 3D™ and CG Future® annuloplasty system

Patients suffering from mitral valve disease and indicated for a mitral valve repair procedure with Profile 3D™ and CG Future® annuloplasty system as part of standard of care, in accordance with the product label indications (instructions for use), contraindications, and warnings

Trial Locations (12)

1216

National Heart Foundation Hospital & Research Institute, Dhaka

380016

U. N. Mehta Institute of Cardiology and Research Centre, Ahmedabad

380054

SAL Hospital & Medical Institute, Ahmedabad

380060

EPIC Hospital, Ahmedabad

400016

P.D. Hinduja National Hospital and Medical Research Centre, Mumbai

500034

CARE Hospitals, Hyderabad

560069

Sri Jayadeva Institute of Cardiovascular Sciences & Research, Bangalore

560099

Narayana Institute of Cardiac Sciences, Bangalore

600037

The Madras Medical Mission, Chennai

641037

G. Kuppuswamy Memorial Hospital, Coimbatore

682041

Amrita Institute of Medical Sciences and Research Center, Kochi

Unknown

Manmohan Cardiothoracic Vascular and Transplant Center, Kathmandu

All Listed Sponsors
lead

Medtronic Cardiac Surgery

INDUSTRY

NCT03283722 - PRESERVE-MITRAL Post-Market Registry | Biotech Hunter | Biotech Hunter